DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Frequently asked questions
What sector does DocMorris AG (DOCM) operate in?
DocMorris AG belongs to the Consumer Staples sector and operates in the Pharmaceutical Retailers industry.
What is DocMorris AG (DOCM) current stock price?
As of the latest data, DocMorris AG stock price is CHF 9.55, with a previous close of CHF 9.46. DocMorris AG gained CHF 0.09 in the last trading session, representing a 0.9% increase.
What is DocMorris AG (DOCM) current market capitalization?
DocMorris AG market cap is approximately 467.60 million.
What is DocMorris AG (DOCM) Earnings Per Share (EPS)?
The trailing EPS is -CHF 4.58, and the forward EPS is -CHF 1.11.
Does DocMorris AG (DOCM) pay dividends?
No. DocMorris AG does not pay a dividend.
When is DocMorris AG (DOCM) next earnings report?
DocMorris AG is expected to release its next earnings report on June 30, 2026.
What is DocMorris AG (DOCM) beta (volatility) score?
DocMorris AG has a beta of 1.864, suggesting it is more volatile than the market.
